ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+33.68%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$782M
AUM Growth
+$782M
(+58%)
Cap. Flow
+$183M
Cap. Flow
% of AUM
23.37%
Top 10 Holdings %
Top 10 Hldgs %
60.14%
Holding
48
New
9
Increased
17
Reduced
9
Closed
6
Top Buys
| 1 |
MDCO
Medicines Co
MDCO
|
$57.9M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$32.4M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$27.7M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$22.5M |
| 5 |
Pacira BioSciences
PCRX
|
$18.7M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$27.7M |
| 2 |
Neurocrine Biosciences
NBIX
|
$20.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$20.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
$16.7M |
| 5 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$12.4M |
Sector Composition
| 1 | Healthcare | 75.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $67.9M | 8.67% | 10,488,076 +1,224,736 | +13% | +$7.92M |
|
|
TSRO
2
DELISTED
TESARO, Inc.
TSRO
| $63.4M | 8.09% | 411,823 +180,123 | +78% | +$27.7M |
|
|
MDCO
3
DELISTED
Medicines Co
MDCO
| $57.9M | 7.4% | +1,185,000 | New | +$57.9M |
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $56M | 7.16% | 1,630,000 +143,540 | +10% | +$4.93M |
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $51.8M | 6.62% | 590,000 +190,000 | +48% | +$16.7M |
|
|
DERM
6
DELISTED
Dermira, Inc.
DERM
| $41M | 5.24% | 1,202,313 +436,604 | +57% | +$14.9M |
|
7
Amicus Therapeutics
FOLD
$2.34B
| $34.6M | 4.42% | 4,847,577 +830,000 | +21% | +$5.92M |
|
8
Iovance Biotherapeutics
IOVA
$807M
| $33.9M | 4.33% | 4,551,343 +30,700 | +0.7% | +$229K |
|
|
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
| $33.8M | 4.32% | 3,780,000 +3,620,000 | +2,263% | +$32.4M |
|
|
GBT
10
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $30M | 3.84% | 815,000 -180,838 | -18% | -$6.66M |
|
|
TLGT
11
DELISTED
Teligent, Inc
TLGT
| $29.6M | 3.78% | 3,791,512 +2,127,893 | +128% | +$16.6M |
|
|
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
| $28.3M | 3.61% | 450,000 +154,467 | +52% | +$9.71M |
|
|
CLVS
13
DELISTED
Clovis Oncology, Inc.
CLVS
| $22.5M | 2.88% | +353,900 | New | +$22.5M |
|
14
Ascendis Pharma
ASND
$11.8B
| $19.6M | 2.51% | 700,924 +155,721 | +29% | +$4.36M |
|
|
AERI
15
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $19.3M | 2.46% | 425,000 -185,000 | -30% | -$8.39M |
|
|
16
Pacira BioSciences
PCRX
$1.2B
| $18.7M | 2.39% | +410,000 | New | +$18.7M |
|
17
Assembly Biosciences
ASMB
$190M
| $17.8M | 2.27% | 696,409 +426,120 | +158% | +$10.9M |
|
|
AVXS
18
DELISTED
AveXis, Inc. Common Stock
AVXS
| $17.1M | 2.19% | +225,370 | New | +$17.1M |
|
|
NDRM
19
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $15.7M | 2% | 590,000 -466,303 | -44% | -$12.4M |
|
20
BioCryst Pharmaceuticals
BCRX
$1.74B
| $13.5M | 1.72% | 1,603,001 -28,501 | -2% | -$239K |
|
|
AGEN
21
Agenus
AGEN
$133M
| $12.7M | 1.62% | 3,368,828 -381,602 | -10% | -$1.44M |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $12.4M | 1.58% | 2,383,201 +875,000 | +58% | +$4.55M |
|
23
Vanda Pharmaceuticals
VNDA
$279M
| $8.64M | 1.1% | 617,200 +235,734 | +62% | +$3.3M |
|
24
Veracyte
VCYT
$2.39B
| $8.33M | 1.06% | 906,999 | – | – |
|
|
ALIM
25
DELISTED
Alimera Sciences, Inc.
ALIM
| $8.11M | 1.04% | 5,791,581 +1,757,093 | +44% | +$2.46M |
|